New Zealand - Import of Heparin for Therapeutic Use
Since 2014, New Zealand Import of Heparin for Therapeutic Use grew 14.9% year on year. At $10,979,320.73 in 2019, the country was number 29 comparing other countries in Import of Heparin for Therapeutic Use. New Zealand is overtaken by Chile, which was number 28 with $11,591,650 and is followed by Argentina at $8,476,312.39. France ranked the highest with $960,128,653.6 in 2019, that is a decrease of 6.6% versus 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize witnessed the best average annual growth at +183.7% per year, while Mauritania was the worst growing country at -81.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 10,979,320.73 |
| 2018 | 11,842,038.00 |
| 2017 | 6,589,569.50 |
| 2016 | 5,351,946.50 |
| 2015 | 6,287,805.00 |
Download all data from 1989 to 2019
How does New Zealand rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
| 28 |
#28
Chile
|
11,591,650.00 | 2019 | +4.7 % | +9.7 % | View data | |
| 29 |
#29
New Zealand
|
10,979,320.73 | 2019 | -7.3 % | +14.9 % | View data | |
| 30 |
#30
Argentina
|
8,476,312.39 | 2019 | +3.4 % | -11.0 % | View data | |